Pharmacokinetic and Safety Profiles of a Fixed‐Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3‐Period Replicate Crossover Study

The objective of study was to compare the pharmacokinetic and safety profiles of a fixed‐dose combination (FDC) formulation of 5/160/20 mg amlodipine/valsartan/atorvastatin with those of separate formulations of a 5/160‐mg amlodipine/valsartan tablet and a 20‐mg atorvastatin tablet. This was a rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seokuee, Ko, Jae‐Wook, Kim, Jung‐Ryul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187173/
https://www.ncbi.nlm.nih.gov/pubmed/31373174
http://dx.doi.org/10.1002/cpdd.727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187173/
https://www.ncbi.nlm.nih.gov/pubmed/31373174
http://dx.doi.org/10.1002/cpdd.727

Ejemplares similares